# Bionano Genomics, Inc.: Form 8-K, filed Nov 13, 2025

- Company: [Bionano Genomics, Inc.](/companies/bngo.md) (CIK 1411690)
- Form: 8-K
- Filed: 2025-11-13
- Accepted by EDGAR: Nov 13, 2025, 16:04 ET
- Period: 2025-11-13
- Accession: 0001411690-25-000092
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1411690/000141169025000092/bngo-20251113.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1411690/000141169025000092/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1411690/000141169025000092/bngo-20251113.htm

Filed Nov 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001411690-25-000092. Last ingested by Listed: Nov 11, 2026, 00:38 ET. No prices; not investment advice.
